GLP3-RT is an investigational synthetic peptide that functions as a triple receptor agonist targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. It has been studied in clinical and preclinical research for its effects on metabolic regulation, energy balance, glucose homeostasis, and lipid metabolism.
Structure: 39-amino-acid synthetic peptide conjugated to a fatty diacid moiety
Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈ (sodium-salt form)
Receptor Activity: GLP-1, GIP, and glucagon receptor agonist
Research Use Only: Not intended for human or veterinary use.